NO311616B1 - Piperazinderivater og fremgangsmåte for fremstilling derav - Google Patents
Piperazinderivater og fremgangsmåte for fremstilling derav Download PDFInfo
- Publication number
- NO311616B1 NO311616B1 NO19980856A NO980856A NO311616B1 NO 311616 B1 NO311616 B1 NO 311616B1 NO 19980856 A NO19980856 A NO 19980856A NO 980856 A NO980856 A NO 980856A NO 311616 B1 NO311616 B1 NO 311616B1
- Authority
- NO
- Norway
- Prior art keywords
- piperazine
- nmr
- cdcl
- yield
- title compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19960025825 | 1996-06-29 | ||
| KR19960025827 | 1996-06-29 | ||
| KR19960025826 | 1996-06-29 | ||
| KR19960040596 | 1996-09-18 | ||
| KR1019970022985A KR100204319B1 (ko) | 1996-06-29 | 1997-06-03 | 신규 피페라진 유도체 및 그 제조방법 |
| KR1019970022984A KR100204320B1 (ko) | 1996-06-29 | 1997-06-03 | 신규 피페라진 유도체 및 그 제조방법 |
| KR1019970023192A KR100204318B1 (ko) | 1996-06-29 | 1997-06-04 | 신규 피페라진 유도체 및 그 제조방법 |
| KR1019970023193A KR100197111B1 (ko) | 1996-09-18 | 1997-06-04 | 신규 피페라진 유도체 및 그 제조방법 |
| PCT/KR1997/000128 WO1998000402A1 (en) | 1996-06-29 | 1997-06-28 | Piperazine derivatives and process for the preparation thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO980856D0 NO980856D0 (no) | 1998-02-27 |
| NO980856L NO980856L (no) | 1998-04-27 |
| NO311616B1 true NO311616B1 (no) | 2001-12-17 |
Family
ID=27573799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19980856A NO311616B1 (no) | 1996-06-29 | 1998-02-27 | Piperazinderivater og fremgangsmåte for fremstilling derav |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6028195A (cs) |
| EP (1) | EP0850222B1 (cs) |
| JP (1) | JP3032303B2 (cs) |
| CN (1) | CN1152015C (cs) |
| AT (1) | ATE241600T1 (cs) |
| AU (1) | AU713171B2 (cs) |
| BG (1) | BG102286A (cs) |
| CA (1) | CA2230960C (cs) |
| CZ (1) | CZ59398A3 (cs) |
| DE (1) | DE69722360T2 (cs) |
| NO (1) | NO311616B1 (cs) |
| NZ (1) | NZ329847A (cs) |
| PL (1) | PL325341A1 (cs) |
| RU (1) | RU2146254C1 (cs) |
| SK (1) | SK27598A3 (cs) |
| TR (1) | TR199800371T1 (cs) |
| WO (1) | WO1998000402A1 (cs) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE384048T1 (de) | 1998-09-22 | 2008-02-15 | Astellas Pharma Inc | Cyanophenyl-derivate |
| US20020065296A1 (en) | 1999-01-13 | 2002-05-30 | Bayer Corporation | Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| EP1158985B1 (en) | 1999-01-13 | 2011-12-28 | Bayer HealthCare LLC | OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
| SI1140840T1 (sl) | 1999-01-13 | 2006-06-30 | Bayer Pharmaceuticals Corp | Omega-karboksiarilno substituirane difenil secnine kot inhibitorji raf kinaze |
| DE60010988T2 (de) * | 1999-03-03 | 2005-06-09 | Samjin Pharmaceutical Co., Ltd. | Piperazinderivate und verfahren zu ihrer herstellung |
| AU8066701A (en) * | 2000-07-20 | 2002-02-05 | Neurogen Corp | Capsaicin receptor ligands |
| DE10035908A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| DE10035928A1 (de) | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| DE10035927A1 (de) | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| IT1318651B1 (it) * | 2000-07-28 | 2003-08-27 | Dompe Spa | Sintesi di (+-)1,3-diossolani e loro risoluzione ottica. |
| CA2444467A1 (en) | 2001-04-18 | 2002-10-24 | Ulrich J. Krull | Gradient resolved hybridisation platform |
| GB0126902D0 (en) * | 2001-11-08 | 2002-01-02 | Novartis Ag | Organic compounds |
| EP1472225B1 (en) | 2002-02-01 | 2010-04-28 | Euro-Celtique S.A. | 2-piperazine-pyridines useful for treating pain |
| BR0312322A (pt) * | 2002-06-28 | 2005-04-12 | Euro Celtique Sa | Compostos, composições, métodos para o tratamento da dor em um animal, da incontinência urinária em um animal, de uma úlcera em um animal, de sìndrome de intestino irritável em um animal, da doença inflamatória do intestino em um animal, métodos para a inibição da função de vr1 em uma célula, kits e métodos para a preparação de uma composição |
| NZ537916A (en) * | 2002-06-29 | 2005-11-25 | Zentaris Gmbh | Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant diseases |
| US7262194B2 (en) * | 2002-07-26 | 2007-08-28 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| US7157462B2 (en) | 2002-09-24 | 2007-01-02 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| BRPI0407088A (pt) * | 2003-01-28 | 2006-01-24 | Aventis Pharma Sa | Produtos n-aril-heteroaromáticos, composições contendo os mesmos e seu uso |
| US20050130989A1 (en) * | 2003-01-28 | 2005-06-16 | Aventis Pharma S. A. | N-arylheteroaromatic products compositions containing them and use thereof |
| WO2004113274A2 (en) | 2003-05-20 | 2004-12-29 | Bayer Pharmaceuticals Corporation | Diaryl ureas with kinase inhibiting activity |
| BRPI0517734A (pt) * | 2004-11-17 | 2008-10-21 | Korea Res Inst Chem Tech | derivados de 1-[(6,7-alcoxiquinoxalinil substituìdo) aminocarbonil]-4- (hetero) arilpiperazina |
| TWI385164B (zh) * | 2005-02-17 | 2013-02-11 | Astellas Pharma Inc | Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivatives (II) |
| US7812025B2 (en) | 2005-08-12 | 2010-10-12 | Takeda Pharmaceutical Company Limited | Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| CA2627875A1 (en) | 2005-10-31 | 2007-05-10 | Bayer Pharmaceuticals Corporation | Combinations comprising sorafenib and interferon for the treatment of cancer |
| WO2009048101A1 (ja) * | 2007-10-10 | 2009-04-16 | Takeda Pharmaceutical Company Limited | アミド化合物 |
| US7946206B2 (en) * | 2007-11-21 | 2011-05-24 | Rocksmart, Llc | Quick-release system |
| TWI434842B (zh) * | 2008-07-14 | 2014-04-21 | Astellas Pharma Inc | Azole compounds |
| US20150376198A1 (en) * | 2013-02-18 | 2015-12-31 | The Scripps Research Institute | Modulators of vasopressin receptors with therapeutic potential |
| TWI836679B (zh) | 2016-02-05 | 2024-03-21 | 美商戴納立製藥公司 | 化合物、組合物及方法 |
| ES2912295T3 (es) | 2016-12-09 | 2022-05-25 | Denali Therapeutics Inc | Compuestos útiles como inhibidores de RIPK1 |
| KR20240132504A (ko) | 2022-01-12 | 2024-09-03 | 데날리 테라퓨틱스 인크. | (s)-5-벤질-n-(5-메틸-4-옥소-2,3,4,5-테트라하이드로피리도 [3,2-b][1,4]옥사제핀-3-일)-4h-1,2,4-트리아졸-3-카복사미드의 결정질 형태 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4016274A (en) * | 1973-05-15 | 1977-04-05 | Rhone-Poulenc S.A. | Naphthyridine derivatives |
| US4038391A (en) * | 1973-05-15 | 1977-07-26 | Rhone-Poulenc S.A. | 6-(1,8-Naphthyridin-2-yl)-5-piperazino carbonyloxy-7-oxo-6,7-dihydro-5H-pyrrolo-[3,4-b]pyrazines and related pyridines |
| OA04700A (fr) * | 1973-05-15 | 1980-07-31 | Rhone Poulenc Sa | Nouveaux dérivés de la naphtyridine et leur procédé de préparation. |
| JPS59222484A (ja) * | 1983-06-02 | 1984-12-14 | Kowa Co | テトラヒドロナフチルカルボン酸フエニルエステル誘導体 |
| JPS63115167A (ja) * | 1986-10-31 | 1988-05-19 | Konica Corp | ハロゲン化銀写真感光材料 |
| US5001160A (en) * | 1988-04-28 | 1991-03-19 | Marion Laboratories, Inc. | 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders |
| US5391571A (en) * | 1989-11-15 | 1995-02-21 | American Home Products Corporation | Cholesterol ester hydrolase inhibitors |
| DE4018070A1 (de) * | 1990-06-06 | 1991-12-12 | Bayer Ag | Morpholinoharnstoff-derivate |
| ZA929008B (en) * | 1991-12-13 | 1993-05-21 | Bristol Myers Squibb Co | Piperazinyl- and piperidinyl-cyclohexanols. |
| DE4216364A1 (de) * | 1991-12-14 | 1993-11-25 | Thomae Gmbh Dr K | Neue Pyridylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| US5461047A (en) * | 1993-06-16 | 1995-10-24 | G. D. Searle & Co. | 2-,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use |
| FR2722788B1 (fr) * | 1994-07-20 | 1996-10-04 | Pf Medicament | Nouvelles piperazides derivees d'aryl piperazine, leurs procedes de preparation, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant |
| PL183865B1 (pl) * | 1995-01-11 | 2002-07-31 | Samjin Pharmaceutical Co | Nowe pochodne piperazyny i środek farmaceutyczny |
-
1997
- 1997-06-28 CZ CZ98593A patent/CZ59398A3/cs unknown
- 1997-06-28 DE DE69722360T patent/DE69722360T2/de not_active Expired - Lifetime
- 1997-06-28 TR TR1998/00371T patent/TR199800371T1/xx unknown
- 1997-06-28 PL PL97325341A patent/PL325341A1/xx unknown
- 1997-06-28 SK SK275-98A patent/SK27598A3/sk unknown
- 1997-06-28 JP JP10504004A patent/JP3032303B2/ja not_active Expired - Fee Related
- 1997-06-28 EP EP97930868A patent/EP0850222B1/en not_active Expired - Lifetime
- 1997-06-28 AU AU34642/97A patent/AU713171B2/en not_active Expired
- 1997-06-28 AT AT97930868T patent/ATE241600T1/de not_active IP Right Cessation
- 1997-06-28 NZ NZ329847A patent/NZ329847A/xx not_active IP Right Cessation
- 1997-06-28 WO PCT/KR1997/000128 patent/WO1998000402A1/en not_active Ceased
- 1997-06-28 RU RU98105684A patent/RU2146254C1/ru active
- 1997-06-28 US US09/029,660 patent/US6028195A/en not_active Expired - Lifetime
- 1997-06-28 CN CNB971908001A patent/CN1152015C/zh not_active Expired - Lifetime
- 1997-06-28 CA CA002230960A patent/CA2230960C/en not_active Expired - Lifetime
-
1998
- 1998-02-27 NO NO19980856A patent/NO311616B1/no unknown
- 1998-02-27 BG BG102286A patent/BG102286A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1152015C (zh) | 2004-06-02 |
| DE69722360D1 (de) | 2003-07-03 |
| EP0850222A1 (en) | 1998-07-01 |
| NO980856D0 (no) | 1998-02-27 |
| WO1998000402A1 (en) | 1998-01-08 |
| BG102286A (en) | 1999-08-31 |
| RU2146254C1 (ru) | 2000-03-10 |
| AU713171B2 (en) | 1999-11-25 |
| PL325341A1 (en) | 1998-07-20 |
| AU3464297A (en) | 1998-01-21 |
| JPH11501680A (ja) | 1999-02-09 |
| CZ59398A3 (cs) | 1998-07-15 |
| JP3032303B2 (ja) | 2000-04-17 |
| NZ329847A (en) | 1999-01-28 |
| EP0850222B1 (en) | 2003-05-28 |
| CA2230960C (en) | 2007-08-28 |
| CA2230960A1 (en) | 1998-01-08 |
| TR199800371T1 (xx) | 1998-06-22 |
| CN1196724A (zh) | 1998-10-21 |
| DE69722360T2 (de) | 2003-11-27 |
| NO980856L (no) | 1998-04-27 |
| ATE241600T1 (de) | 2003-06-15 |
| SK27598A3 (en) | 1998-11-04 |
| US6028195A (en) | 2000-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO311616B1 (no) | Piperazinderivater og fremgangsmåte for fremstilling derav | |
| Misra et al. | Organocatalyzed highly atom economic one pot synthesis of tetrahydropyridines as antimalarials | |
| US5780472A (en) | Piperazine derivatives and methods for the preparation thereof and compositions containing the same | |
| Chipeleme et al. | Synthesis and biological evaluation of phenolic Mannich bases of benzaldehyde and (thio) semicarbazone derivatives against the cysteine protease falcipain-2 and a chloroquine resistant strain of Plasmodium falciparum | |
| EP1075469A1 (en) | Piperazine derivatives and process for the preparation thereof | |
| CN102250065A (zh) | 取代的三嗪苯脲衍生物及其用途 | |
| TW580498B (en) | A novel amide compound and a pharmaceutical composition containing the same | |
| Pati et al. | Novel metal chelators thiosemicarbazones with activity at the σ 2 receptors and P-glycoprotein: an innovative strategy for resistant tumor treatment | |
| JPWO2008018529A1 (ja) | 新規なベンジル（ピリジルメチル）アミン構造を有するピリミジン化合物及びこれを含有する医薬 | |
| AU2002235040B2 (en) | 9-Aminoacridine derivatives and process for the preparation thereof | |
| WO2005072733A1 (en) | Dyarylurea compounds as chk-1 inhibitors | |
| CN102174035A (zh) | 芳香双酰肼类plk1抑制剂及其用途 | |
| Arias et al. | Bioactive imidamide-based compounds targeted against nitric oxide synthase | |
| HUP9903870A2 (hu) | Piperazinszármazékok és eljárás ezen vegyületek előállítására | |
| RU2126001C1 (ru) | Производные пиперазина и фармацевтическая композиция на их основе | |
| KR100197111B1 (ko) | 신규 피페라진 유도체 및 그 제조방법 | |
| Pentimalli | Preparation and peracid oxidation of 2-(p-dimethylamino)-styryl-pyridine | |
| KR100204318B1 (ko) | 신규 피페라진 유도체 및 그 제조방법 | |
| MXPA98001658A (en) | Derivatives of piperazine and process for the preparation of the mis | |
| NO783775L (no) | 2,4-diamino-5-benzylpyrimidiner og fremgangsmaate ved fremstilling av disse | |
| KR100204320B1 (ko) | 신규 피페라진 유도체 및 그 제조방법 | |
| Lebegue et al. | Synthesis of 4-methoxybenzylamino derivatives of dibenzothiadiazepinedioxide | |
| JP2010502666A (ja) | 複素環ピリジルスルホンアミド誘導体、これらの製造方法、及び薬剤としての使用 | |
| KR20000059356A (ko) | 피페라진 유도체 및 그 제조방법 | |
| KR19980076946A (ko) | 신규 피페라진 n-옥사이드 유도체 및 그 제조방법 |